Location · Boston, MA
Clinical trials in Boston, MA
787 recruiting studies have a site in the Boston area, and 318 of them accept healthy volunteers. The area includes Cambridge, Brookline, Newton, Waltham, Burlington, Chestnut Hill and nearby cities.
787 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Amgen
- Location
- La Jolla, CA + 3 other US sites
- Eligibility basics
- Ages 2–17
- Recruiting
Home Use Study of Targeted Mechanical Stimulation for Tremor Relief
Encora, Inc.
- Location
- Cambridge, MA
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis
60 Degrees Pharmaceuticals LLC
- Location
- Boston, MA
- Eligibility basics
- Ages 18+
- Recruiting
STIMIT Activator 1 IDE Study
Stimit AG
- Location
- New Haven, CT + 2 other US sites
- Eligibility basics
- Ages 21+
- Recruiting
A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal Fistulas
RedDress Ltd.
- Location
- Weston, FL + 7 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Access Cannulation Trial II
Voyager Biomedical
- Location
- Dothan, AL + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Neurocrine Biosciences
- Location
- Little Rock, AR + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Phoenix, AZ + 34 other US sites
- Eligibility basics
- Ages 12–18
- RecruitingPhase 1/Phase 2
Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial
Wandercraft
- Location
- Boston, MA
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
Medicure
- Location
- Birmingham, AL + 4 other US sites
- Eligibility basics
- Any age listed
- Recruiting
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
Aria CV, Inc
- Location
- Los Angeles, CA + 8 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Birmingham, AL + 57 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
AB Science
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–81
- Recruiting
GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial
Genomic Prediction Inc.
- Location
- Waltham, MA
- Eligibility basics
- Ages 35–40 · Women only
- Recruiting
Smartphone Services for Stimulant Use Disorder
DynamiCare Health
- Location
- Boston, MA
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
GIE Medical
- Location
- Scottsdale, AZ + 32 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
GIE Medical
- Location
- Scottsdale, AZ + 30 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 2
Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis
Tiziana Life Sciences LTD
- Location
- Boston, MA
- Eligibility basics
- Ages 18–75
- Recruiting
A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System
Vectorious Medical Technologies Ltd.
- Location
- Boston, MA
- Eligibility basics
- Ages 22–88
- RecruitingPhase 1/Phase 2
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
Splice Bio
- Location
- Aurora, CO + 4 other US sites
- Eligibility basics
- Ages 12–65
- RecruitingPhase 1
Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL
Ascentage Pharma Group Inc.
- Location
- Duarte, CA + 6 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
Otsuka Pharmaceutical Development & Commercialization, Inc.
- Location
- Denver, CO + 3 other US sites
- Eligibility basics
- Ages 16+
- Recruiting
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System
HighLife SAS
- Location
- Tucson, AZ + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Tenaya Therapeutics
- Location
- San Francisco, CA + 6 other US sites
- Eligibility basics
- Ages 18–65